Insider trades
David Bredt, Chief Officer of Rapport Therapeutics RAPP, has filed 0 purchases and 21 sales on the open market. Over the past 12 months that comes to a net sale of $1.4M. The latest trade was on 02/19.
David Bredt
Chief Scientific Officer
- Company
- Rapport Therapeutics RAPP
- First filing
- 24/06/10
- Trades
- 27 trades
- Buys / sales
- 0 / 21
- 12-month net buying
- −$1.4M
- Last trade
- 02/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RAPP | Open-market sale10b5-1 plan | 02/17 | 02/19 | 8,500 sh3 trades | $29.02avg. | $246,646 | −2.1% |
RAPP | Open-market sale10b5-1 plan | 01/15 | 01/16 | 8,500 sh2 trades | $26.84avg. | $228,169 | −2.1% |
| Open-market sale | 25/12/31 | 01/05 | 6,567 sh | $30.05 | $197,338.35 | −1.6% | |
RAPP | Open-market sale10b5-1 plan | 25/12/15 | 25/12/16 | 8,500 sh2 trades | $30.02avg. | $255,156.08 | −2.1% |
RAPP | Open-market sale10b5-1 plan | 25/11/17 | 25/11/18 | 8,500 sh2 trades | $25.19avg. | $214,079.2 | −2.1% |
RAPP | Open-market sale10b5-1 plan | 25/10/15 | 25/10/16 | 8,500 sh2 trades | $25.78avg. | $219,170.26 | −2.0% |
RAPP | Open-market sale10b5-1 plan | 25/09/15 | 25/09/17 | 8,500 sh2 trades | $24.19avg. | $205,633.56 | −2.0% |
RAPP | Open-market sale10b5-1 plan | 25/08/15 | 25/08/18 | 8,500 sh2 trades | $15.00avg. | $127,492 | −2.0% |
| Open-market sale10b5-1 plan | 25/07/15 | 25/07/16 | 8,500 sh | $14.00 | $119,000 | −1.9% | |
| Open-market sale10b5-1 plan | 25/06/16 | 25/06/18 | 8,500 sh | $11.00 | $93,500 | −1.9% | |
| Open-market sale10b5-1 plan | 25/05/15 | 25/05/19 | 8,500 sh | $9.56 | $81,260 | −1.8% | |
| Open-market sale10b5-1 plan | 25/04/15 | 25/04/16 | 8,500 sh | $9.57 | $81,345 | −1.8% | |
| Open-market sale10b5-1 plan | 25/03/14 | 25/03/17 | 8,500 sh | $10.85 | $92,225 | −1.8% |